A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3 Onur Erdogan; Ekrem Karaayvaz; Tugba Erdogan; Cafer Panc; Remzi Sar¿kaya; Aytac Oncul; Ahmet Kaya Bilge;

Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping Mário Oliveira; Pedro Cunha; Bruno Valente; Guilherme Portugal; Ana Lousinha; Mariana Pereira; Manuel Braz; Ana Delgado; Rui C. Ferreira;

Ablation of ventricular arrhythmic substrate: When the whole is more than the sum of its parts João Primo;